Capital Investment Advisors’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $288K | Sell |
6,296
-685
| -10% | -$31.4K | 0.01% | 579 |
|
|
2025
Q1 | $336K | Sell |
6,981
-3,015
| -30% | -$145K | 0.01% | 518 |
|
|
2024
Q4 | $506K | Sell |
9,996
-549
| -5% | -$27.8K | 0.01% | 418 |
|
|
2024
Q3 | $672K | Hold |
10,545
| – | – | 0.01% | 359 |
|
|
2024
Q2 | $625K | Sell |
10,545
-350
| -3% | -$20.7K | 0.01% | 360 |
|
|
2024
Q1 | $627K | Sell |
10,895
-430
| -4% | -$24.7K | 0.01% | 361 |
|
|
2023
Q4 | $646K | Sell |
11,325
-525
| -4% | -$30K | 0.02% | 337 |
|
|
2023
Q3 | $568K | Sell |
11,850
-1,050
| -8% | -$50.4K | 0.02% | 332 |
|
|
2023
Q2 | $671K | Sell |
12,900
-625
| -5% | -$32.5K | 0.02% | 299 |
|
|
2023
Q1 | $733K | Sell |
13,525
-270
| -2% | -$14.6K | 0.02% | 289 |
|
|
2022
Q4 | $796K | Hold |
13,795
| – | – | 0.02% | 277 |
|
|
2022
Q3 | $657K | Sell |
13,795
-300
| -2% | -$14.3K | 0.02% | 297 |
|
|
2022
Q2 | $682K | Sell |
14,095
-150
| -1% | -$7.26K | 0.02% | 302 |
|
|
2022
Q1 | $884K | Buy |
14,245
+185
| +1% | +$11.5K | 0.03% | 283 |
|
|
2021
Q4 | $1.14M | Buy |
14,060
+200
| +1% | +$16.2K | 0.03% | 254 |
|
|
2021
Q3 | $1.32M | Buy |
13,860
+78
| +0.6% | +$7.41K | 0.04% | 230 |
|
|
2021
Q2 | $1.36M | Buy |
13,782
+500
| +4% | +$49.3K | 0.05% | 225 |
|
|
2021
Q1 | $1.11M | Buy |
13,282
+14
| +0.1% | +$1.17K | 0.04% | 237 |
|
|
2020
Q4 | $1.15M | Buy |
13,268
+13
| +0.1% | +$1.12K | 0.05% | 223 |
|
|
2020
Q3 | $927K | Buy |
13,255
+835
| +7% | +$58.4K | 0.04% | 236 |
|
|
2020
Q2 | $902K | Buy |
12,420
+2,750
| +28% | +$200K | 0.05% | 233 |
|
|
2020
Q1 | $448K | Buy |
9,670
+225
| +2% | +$10.4K | 0.03% | 295 |
|
|
2019
Q4 | $583K | Buy |
9,445
+300
| +3% | +$18.5K | 0.03% | 301 |
|
|
2019
Q3 | $389K | Sell |
9,145
-500
| -5% | -$21.3K | 0.02% | 346 |
|
|
2019
Q2 | $500K | Buy |
9,645
+455
| +5% | +$23.6K | 0.03% | 312 |
|
|
2019
Q1 | $510K | Buy |
9,190
+130
| +1% | +$7.21K | 0.03% | 303 |
|
|
2018
Q4 | $381K | Sell |
9,060
-800
| -8% | -$33.6K | 0.03% | 327 |
|
|
2018
Q3 | $687K | Buy |
9,860
+875
| +10% | +$61K | 0.04% | 250 |
|
|
2018
Q2 | $514K | Buy |
8,985
+525
| +6% | +$30K | 0.03% | 289 |
|
|
2018
Q1 | $466K | Buy |
8,460
+3,850
| +84% | +$212K | 0.03% | 306 |
|
|
2017
Q4 | $258K | Buy |
4,610
+65
| +1% | +$3.64K | 0.02% | 407 |
|
|
2017
Q3 | $278K | Buy |
+4,545
| New | +$278K | 0.02% | 382 |
|